Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.

[1]  K. Preissner,et al.  Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). , 1988, The Journal of biological chemistry.

[2]  L. Nelles,et al.  Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1). , 1988, European journal of biochemistry.

[3]  R. Nachman,et al.  Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment. , 1988, The Journal of biological chemistry.

[4]  J. Kane,et al.  Formation of recombinant protein inclusion bodies in Escherichia coli , 1988 .

[5]  D. Loskutoff,et al.  Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms. , 1988, Biochemistry.

[6]  B. Wiman,et al.  Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions. , 1988, The Biochemical journal.

[7]  D. Loskutoff,et al.  Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator. , 1988, Archives of biochemistry and biophysics.

[8]  J. V. van Mourik,et al.  ACTIVATION OF HUMAN ENDOTHELIAL TYPE PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) BY NEGATIVELY CHARGED PHOSPHOLIPIDS , 1987, Thrombosis and Haemostasis.

[9]  A. Ben-Bassat,et al.  Amino-terminal processing of proteins , 1987, Nature.

[10]  C. Kluft,et al.  Plasminogen activator inhibitors. , 1987, Blood.

[11]  F. Blasi,et al.  Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencing , 1986, FEBS letters.

[12]  R. Lebo,et al.  cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. , 1986, The Journal of clinical investigation.

[13]  F. Marston.  The purification of eukaryotic polypeptides synthesized in Escherichia coli. , 1986, The Biochemical journal.

[14]  H. Lambers,et al.  Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. , 1986, The EMBO journal.

[15]  E. Levin.  Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells , 1986 .

[16]  D. Loskutoff,et al.  Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. , 1985, The Journal of biological chemistry.

[17]  R. Carrell,et al.  α1-Antitrypsin and the serpins: variation and countervariation , 1985, Trends in Biochemical Sciences.

[18]  R. Huber,et al.  Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. , 1984, Journal of molecular biology.

[19]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[20]  L. Erickson,et al.  Neutralization by plasminogen activator inhibitor-1 of mutants of tissue plasminogen activator. , 1988, Enzyme.

[21]  C. Gerard,et al.  Human C5a anaphylatoxin: gene synthesis, expression, and recovery of biologically active material from Escherichia coli. , 1988, Methods in enzymology.

[22]  T. Wun,et al.  cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell , 1987, FEBS letters.

[23]  G. Salvesen,et al.  Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.

[24]  R. Hawkes,et al.  A dot-immunobinding assay for monoclonal and other antibodies. , 1982, Analytical biochemistry.